메뉴 건너뛰기




Volumn 134, Issue 3, 2012, Pages 1027-1039

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

Author keywords

Androgen; Aromatase inhibitor; Breast cancer; Endocrine resistance; Estrogen

Indexed keywords

3BETA ANDROSTANEDIOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PHOSPHOTRANSFERASE INHIBITOR;

EID: 84868200933     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2032-6     Document Type: Article
Times cited : (24)

References (40)
  • 1
    • 78649603622 scopus 로고    scopus 로고
    • Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer:10-year analysis of the ATAC trial
    • doi:10.1016/S1470-2045 10 70257-6
    • Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer:10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135-1141. doi:10.1016/S1470-2045 (10) 70257-6
    • (2010) Lancet Oncol , vol.11 , Issue.12 , pp. 1135-1141
    • Cuzick, J.1    Sestak, I.2    Baum, M.3    Buzdar, A.4    Howell, A.5    Dowsett, M.6    Forbes, J.F.7
  • 3
    • 25844472419 scopus 로고    scopus 로고
    • Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation
    • doi:10.1677/erc.1.01023
    • Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M (2005) Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation. Endocr Relat Cancer 12(Suppl 1):S75-S84. doi:10.1677/erc.1.01023
    • (2005) Endocr Relat Cancer , vol.12 , Issue.SUPPL. 1
    • Martin, L.A.1    Farmer, I.2    Johnston, S.R.3    Ali, S.4    Dowsett, M.5
  • 4
    • 0042232592 scopus 로고    scopus 로고
    • Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation
    • doi:10.1074/jbc. M305226200
    • Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M (2003) Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation. J Biol Chem 278(33):30458-30468. doi:10.1074/jbc. M305226200
    • (2003) J Biol Chem , vol.278 , Issue.33 , pp. 30458-30468
    • Martin, L.A.1    Farmer, I.2    Johnston, S.R.3    Ali, S.4    Marshall, C.5    Dowsett, M.6
  • 5
    • 0028853923 scopus 로고
    • Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
    • Masamura S, Santner SJ, Heitjan DF, Santen RJ (1995) Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80(10):2918-2925
    • (1995) J Clin Endocrinol Metab , vol.80 , Issue.10 , pp. 2918-2925
    • Masamura, S.1    Santner, S.J.2    Heitjan, D.F.3    Santen, R.J.4
  • 6
    • 49649086490 scopus 로고    scopus 로고
    • Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells
    • Santen RJ, Song RX, Masamura S, Yue W, Fan P, Sogon T, Hayashi S, Nakachi K, Eguchi H (2008) Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. Adv Exp Med Biol 630:19-34
    • (2008) Adv Exp Med Biol , vol.630 , pp. 19-34
    • Santen, R.J.1    Song, R.X.2    Masamura, S.3    Yue, W.4    Fan, P.5    Sogon, T.6    Hayashi, S.7    Nakachi, K.8    Eguchi, H.9
  • 8
    • 84860390340 scopus 로고    scopus 로고
    • Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
    • doi:10.1186/bcr2833
    • Sanchez CG, Ma CX, Crowder RJ, Guintoli T, Phommaly C, Gao F, Lin L, Ellis MJ (2011) Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer. Breast Cancer Res 13(2):R21. doi:10.1186/bcr2833
    • (2011) Breast Cancer Res , vol.13 , Issue.2
    • Sanchez, C.G.1    Ma, C.X.2    Crowder, R.J.3    Guintoli, T.4    Phommaly, C.5    Gao, F.6    Lin, L.7    Ellis, M.J.8
  • 10
    • 0035992421 scopus 로고    scopus 로고
    • The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: Long-term studies using the intratumoral aromatase postmenopausal breast cancer model
    • Long BJ, Jelovac D, Thiantanawat A, Brodie AM (2002) The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model. Clin Cancer Res 8(7):2378-2388
    • (2002) Clin Cancer Res , vol.8 , Issue.7 , pp. 2378-2388
    • Long, B.J.1    Jelovac, D.2    Thiantanawat, A.3    Brodie, A.M.4
  • 11
    • 79960264282 scopus 로고    scopus 로고
    • Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance
    • doi:10.1016/j.mce. 2010.09.005
    • Sabnis G, Brodie A (2011) Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance. Mol Cell Endocrinol. doi:10.1016/j.mce. 2010.09.005
    • (2011) Mol Cell Endocrinol.
    • Sabnis, G.1    Brodie, A.2
  • 12
    • 67349101669 scopus 로고    scopus 로고
    • The androgen metabolite 5alpha-androstane-3beta, 17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: Implications for aromatase inhibitor resistance
    • doi:10.1007/s10549-008-0080-8
    • Sikora MJ, Cordero KE, Larios JM, Johnson MD, Lippman ME, Rae JM (2009) The androgen metabolite 5alpha-androstane-3beta, 17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Res Treat 115(2):289-296. doi:10.1007/s10549-008-0080-8
    • (2009) Breast Cancer Res Treat , vol.115 , Issue.2 , pp. 289-296
    • Sikora, M.J.1    Cordero, K.E.2    Larios, J.M.3    Johnson, M.D.4    Lippman, M.E.5    Rae, J.M.6
  • 14
    • 82955249033 scopus 로고    scopus 로고
    • Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy
    • doi:10.1007/s10549-011-1611-2
    • Gallicchio L, Macdonald R, Wood B, Rushovich E, Helzlsouer KJ (2011) Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy. Breast Cancer Res Treat. doi:10.1007/s10549-011-1611-2
    • (2011) Breast Cancer Res Treat.
    • Gallicchio, L.1    Macdonald, R.2    Wood, B.3    Rushovich, E.4    Helzlsouer, K.J.5
  • 16
    • 43249113162 scopus 로고    scopus 로고
    • Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer
    • doi:10.1200/JCO.2007.13.9279
    • Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A'Hern RP, Dowsett M (2008) Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. J Clin Oncol 26(10):1671-1676. doi:10.1200/JCO.2007.13.9279
    • (2008) J Clin Oncol , vol.26 , Issue.10 , pp. 1671-1676
    • Dixon, J.M.1    Renshaw, L.2    Young, O.3    Murray, J.4    Macaskill, E.J.5    McHugh, M.6    Folkerd, E.7    Cameron, D.A.8    A'Hern, R.P.9    Dowsett, M.10
  • 18
    • 0018940905 scopus 로고
    • Lippman ME (1980) The effects of 17b estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium
    • Allegra JC (1965) Lippman ME (1980) The effects of 17b estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium. Eur J Cancer 16(8):1007-1015
    • (1965) Eur J Cancer , vol.16 , Issue.8 , pp. 1007-1015
    • Allegra, J.C.1
  • 19
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-delta delta C (T)) method
    • doi:10.1006/meth.2001.1262
    • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-delta delta C (T)) method. Methods 25(4):402-408. doi:10.1006/meth.2001.1262
    • (2001) Methods , vol.25 , Issue.4 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 20
    • 79960264727 scopus 로고    scopus 로고
    • New and translational perspectives of oestrogen deprivation in breast cancer
    • doi:10.1016/j.mce.2010.12.034
    • Dunbier AK, Martin LA, Dowsett M (2011) New and translational perspectives of oestrogen deprivation in breast cancer. Mol Cell Endocrinol. doi:10.1016/j.mce.2010.12.034
    • (2011) Mol Cell Endocrinol.
    • Dunbier, A.K.1    Martin, L.A.2    Dowsett, M.3
  • 21
    • 0035971181 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: A new model for anti-estrogen resistance
    • doi:10.1074/jbc
    • Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276(13):9817-9824. doi:10.1074/jbc
    • (2001) J Biol Chem , vol.276 , Issue.13 , pp. 9817-9824
    • Campbell, R.A.1    Bhat-Nakshatri, P.2    Patel, N.M.3    Constantinidou, D.4    Ali, S.5    Nakshatri, H.6
  • 23
    • 33751552134 scopus 로고    scopus 로고
    • Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity
    • doi:10.1210/me.2006-0068
    • Likhite VS, Stossi F, Kim K, Katzenellenbogen BS, Katzenellenbogen JA (2006) Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol Endocrinol 20(12):3120-3132. doi:10.1210/me.2006-0068
    • (2006) Mol Endocrinol , vol.20 , Issue.12 , pp. 3120-3132
    • Likhite, V.S.1    Stossi, F.2    Kim, K.3    Katzenellenbogen, B.S.4    Katzenellenbogen, J.A.5
  • 24
    • 2942592008 scopus 로고    scopus 로고
    • Dual kinase inhibition in the treatment of breast cancer: Initial experience with the EGFR/ErbB-2 inhibitor lapatinib
    • Burris HA III (2004) Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 9(Suppl 3):10-15
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 3 , pp. 10-15
    • Burris III, H.A.1
  • 25
    • 33751205030 scopus 로고    scopus 로고
    • Lapatinib: Current status and future directions in breast cancer
    • doi:10.1634/theoncologist.11-10-1047
    • Moy B, Goss PE (2006) Lapatinib: current status and future directions in breast cancer. Oncologist 11(10):1047-1057. doi:10.1634/theoncologist.11-10-1047
    • (2006) Oncologist , vol.11 , Issue.10 , pp. 1047-1057
    • Moy, B.1    Goss, P.E.2
  • 26
    • 39149111976 scopus 로고    scopus 로고
    • Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
    • doi:10.1200/JCO.2007.11.5451
    • Partridge AH, La Fountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556-562. doi:10.1200/JCO.2007.11. 5451
    • (2008) J Clin Oncol , vol.26 , Issue.4 , pp. 556-562
    • Partridge, A.H.1    La Fountain, A.2    Mayer, E.3    Taylor, B.S.4    Winer, E.5    Asnis-Alibozek, A.6
  • 30
    • 78649701331 scopus 로고    scopus 로고
    • Targeting endocrine resistance: Is there a role for mTOR inhibition?
    • Sheri A, Martin L-A, Johnston S (2010) Targeting endocrine resistance: Is there a role for mTOR inhibition? Clin Breast Cancer 10:S79-S85
    • (2010) Clin Breast Cancer , vol.10
    • Sheri, A.1    Martin, L.-A.2    Johnston, S.3
  • 33
    • 38049008502 scopus 로고    scopus 로고
    • 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator
    • doi:10.1210/me.2007-0383
    • Du Sell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP (2008) 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 22(1):65-77. doi:10.1210/me.2007-0383
    • (2008) Mol Endocrinol , vol.22 , Issue.1 , pp. 65-77
    • Du Sell, C.D.1    Umetani, M.2    Shaul, P.W.3    Mangelsdorf, D.J.4    McDonnell, D.P.5
  • 34
    • 0024500567 scopus 로고
    • Androstenedione and androst-5-ene-3b, 17b-diol stimulate DMBA-induced rat mammary tumors-role of aromatase
    • doi:10.1007/bf01806551
    • Dauvois S, Labrie F (1989) Androstenedione and androst-5-ene-3b, 17b-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res Treat 13(1):61-69. doi:10.1007/bf01806551
    • (1989) Breast Cancer Res Treat , vol.13 , Issue.1 , pp. 61-69
    • Dauvois, S.1    Labrie, F.2
  • 35
    • 79956106152 scopus 로고    scopus 로고
    • Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer
    • Stanway SJ, Palmieri C, Stanczyk FZ, Folkerd EJ, Dowsett M, Ward R, Coombes RC, Reed MJ, Purohit A (2011) Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer. Anticancer Res 31(4):1367-1372
    • (2011) Anticancer Res , vol.31 , Issue.4 , pp. 1367-1372
    • Stanway, S.J.1    Palmieri, C.2    Stanczyk, F.Z.3    Folkerd, E.J.4    Dowsett, M.5    Ward, R.6    Coombes, R.C.7    Reed, M.J.8    Purohit, A.9
  • 36
    • 0022899836 scopus 로고
    • Intratissular androgens in benign prostatic hyperplasia and prostatic cancer
    • Voigt KD, Bartsch W (1986) Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J Steroid Biochem 25 (5 B):749-757
    • (1986) J Steroid Biochem , vol.25 , Issue.5 B , pp. 749-757
    • Voigt, K.D.1    Bartsch, W.2
  • 37
    • 34250878367 scopus 로고    scopus 로고
    • Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy
    • Santen RJ, Demers L, Ohorodnik S, Settlage J, Langecker P, Blanchett D, Goss PE, Wang S (2007) Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 72(8):666-671
    • (2007) Steroids , vol.72 , Issue.8 , pp. 666-671
    • Santen, R.J.1    Demers, L.2    Ohorodnik, S.3    Settlage, J.4    Langecker, P.5    Blanchett, D.6    Goss, P.E.7    Wang, S.8
  • 39
    • 70249128382 scopus 로고    scopus 로고
    • Enhancing the efficacy of hormonal agents with selected targeted agents
    • doi:10.3816/CBC.2009.s.003
    • Johnston SR (2009) Enhancing the efficacy of hormonal agents with selected targeted agents. Clin Breast Cancer 9(Suppl 1):S28-S36. doi:10.3816/CBC.2009.s.003
    • (2009) Clin Breast Cancer , vol.9 , Issue.SUPPL. 1
    • Johnston, S.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.